From: Effect of herbal compounds on coronavirus; a systematic review and meta-analysis
Ref | Virus strain/host | Drug name/plant | Main outcomes | exposure time/hours | SI(CC50/IC50) | EC50 | Â |
---|---|---|---|---|---|---|---|
[37] | MERS-COV-2/MRC-5 | Silvestrol/ Meliaceae | SI, Virus titer | 24 h |  > 7690 | 0.0013 µM/L |  |
 | HCoV-229E/ MRC-5 |  |  |  |  > 3330 | 0.003 µM/L |  |
 | HCoV-229E/ PBMCs |  |  |  |  > 350 | 0.0028 µM/L |  |
 | HCoV-229E/ Huh-7 |  |  |  |  > 0.75 | 0.040 µM/L |  |
[9] | HCoV-229E/ MRC-5 | Saikosaponins B2/ Bupleurum | SI, EC50, Virus inhibition | 96 h | 221.9 | 1.7 ± 0.1 µM/L |  |
 |  | Saikosaponin A/ Bupleurum |  |  | 26.6 | 8.6 ± 0.3 µM/L |  |
 |  | Saikosaponin C/ Bupleurum |  |  | 19.2 | 19.9 ± 0.1 µM/L |  |
 |  | Saikosaponin D/ Bupleurum |  |  | 13.3 | 13.2 ± 0.3 µM/L |  |
[7] | SARS-COV strain FFM 1/ African green monkey kidney cell lines Vero | Extract/Yin-Chiau-San | SI, EC50 | 72 h |  > 1 |  > 500(µg/ml) |  |
 |  | Extract/ Pu-Zhi-Siau-Du-Yien |  |  |  > 2 | 240(µg/ml) |  |
 |  | Extract/ Ger-Gern-Hwang-Lein |  |  |  > 3 | 134(µg/ml) |  |
 |  | Extract/ Sang-Zhiu-Yien |  |  |  > 1 | 349(µg/ml) |  |
 |  | Extract/ Huang-Lein-Zhei-Du-Tang |  |  |  > 1 | 369(µg/ml) |  |
 |  | Extract/ Toona sinensis leaves |  |  | 17 | 30(µg/ml) |  |
 |  | Extract/ Toona sinensis leaves |  |  |  > 13 | 37 (µg/ml) |  |
 |  | Extract /Amaryllidaceae |  |  | 370 | 2.4 (± 0.2) (µg/ml) |  |
[25] | SARS-COV (BJ-001)/ Vero E6 cells | Artemisia annua | SI, EC50, Virus inhibition, | 72 h | 31 | 34.5(± 2.6) (µg/ml) |  |
 |  | Pyrrosia lingua |  |  | 55 | 43.2(± 14.1) (µg/ml) |  |
 |  | Lindera aggregate |  |  | 16 | 88.2(± 7.7) (µg/ml) |  |
 | SARS-COV (BJ-002)/ Vero E6 cells | Extract/ Lycoris radiata /Amaryllidaceae |  |  | 422 | 2.1 (± 0.2) (µg/ml) |  |
 |  | Artemisia annua |  |  | 27 | 39.2 (± 4.1) (µg/ml) |  |
 |  | Pyrrosia lingua |  |  | 59 | 40.5 (± 3.7) (µg/ml) |  |
 |  | Lindera aggregate |  |  | 17 | 80.6 (± 5.2) (µg/ml) |  |
[53] | HCoV-NL63/ LLC-MK2 cells, Calu-3 cells | Caffeic acid /Adoxaceae Chlorogenic acid/Adoxaceae Gallic acid/Adoxaceae | Virus inhibition, Virus titer | Â | NR | NR | Â |
[20] | SARS-COV / Vero E6 cells | Lectin (Man-specific agglutinins)(APA/ Alliaceae | SI, EC50 | 72 |  > 222.2 | 0.45 ± 0.08(µg/ml) |  |
 |  | Mannose-specific agglutinins( HHA) |  |  |  > 31.3 | 3.2 ± 2.8(µg/ml) |  |
 |  | Mannose-specific agglutinins( GNA) |  |  |  > 16.1 | 6.2 ± 0.6(µg/ml) |  |
 |  | Mannose-specific agglutinins( NPA) |  |  |  > 17.5 | 5.7 ± 4.4(µg/ml) |  |
 |  | Mannose-specific agglutinins( LRA) |  |  |  > 2.1 | 48(µg/ml) |  |
 |  | Mannose-specific agglutinins(AUA) |  |  |  > 5.5 | 18 ± 4(µg/ml) |  |
 |  | Mannose-specific agglutinins( CA) |  |  |  > 20 | 4.9 ± 0.8(µg/ml) |  |
 |  | Mannose-specific agglutinins( LOA) |  |  |  > 45.5 | 2.2 ± 1.3(µg/ml) |  |
 |  | Mannose-specific agglutinins( EHA) |  |  |  > 55.5 | 1.8 ± 0.3(µg/ml) |  |
 |  | Mannose-specific agglutinins( TLMI) |  |  |  > 2.3 | 22 ± 6(µg/ml) |  |
 |  | Mannose-specific agglutinins( Morniga M II) |  |  |  > 62.5 | 1.6 ± 0.5(µg/ml) |  |
 |  | GlcNAc-specific agglutinins Nictaba |  |  |  > 58.8 | 1.7 ± 0.3(µg/ml) |  |
 |  | (GlcNAc)n-specific agglutinins UDA |  |  |  > 76.9 | 1.3 ± 0.1(µg/ml) |  |
 |  | Gal-specific agglutinins Morniga G II |  |  |  > 2 | 50 ± 13(µg/ml) |  |
 |  | Man/Glc-specific agglutinins Cladistris |  |  |  > 13.5 | 7.4 ± 0.2(µg/ml) |  |
 |  | Gal/GalNAc specific agglutinins -PMRIP m |  |  |  > 5.5 | 18 ± 13(µg/ml) |  |
 |  | GalNAc (> Gal) specific agglutinins/ ML III |  |  |  > 12.6 | 28 ± 11(µg/ml) |  |
 |  | GalNAcα(1,3)Gal > GalNAc > Gal-specific agglutinins/IRA |  |  | 22.7 | 2.2 ± 0.9(µg/ml) |  |
 |  | GalNAcα(1,3)Gal > GalNAc > Gal-specific agglutinins/IRA |  |  | 8.2 | 4.4 ± 3.1(µg/ml) |  |
 |  | GalNAcα(1,3)Gal > GalNAc > Gal-specific agglutinins/IRA |  |  | 16.2 | 3.4 ± 2.0(µg/ml) |  |
 |  | Man/GalNAc-specific agglutinins/ TL C II |  |  |  > 1.3 | 38 ± 0(µg/ml) |  |
[22] | SARS-COV, Toronto-2 v2147/ Vero 76 | Lectin (N-acetylglucosamine)/ Urticaceae | SI, Virus titer | 72 h | 54.2 ± 52.5 | NR |  |
 | SARS-COV, Urbani/ Vero 76 |  |  |  | 10.2 ± 5.6 | NR |  |
 | SARS-COV, Mouse-adapted virus/ Vero 76 |  |  |  | 42.8 ± 47.5 | NR |  |
 | SARS-COV, Frankfurt v1940/ Vero 76 |  |  |  | 5.5 ± 2.0 | NR |  |
 | SARS-COV, Hong Kong v2157/ Vero 76 |  |  |  | 8.6 ± 1.1 | NR |  |
[23] | Vero-adapted Beaudette IBV/ Vero | Ethanol extract/ Lamiaceae | SI, EC50, Virus titer | 72 h | 67.5 | 0.004 (µg/ml) |  |
 | Vero-adapted Beaudette IBV/ Satureja montana |  |  |  | 17 | 0.044(µg/ml) |  |
 | Vero-adapted Beaudette IBV/Origanum vulgare |  |  |  | 65 | 0.008(µg/ml) |  |
 | Vero-adapted Beaudette IBV/Mentha piperita |  |  |  | 67.5 | 0.015(µg/ml) |  |
 | Vero-adapted Beaudette IBV/Melissa officinalis |  |  |  | 39.3 | 0.010(µg/ml) |  |
 | Vero-adapted Beaudette IBV/Hyssopus officinalis, |  |  |  | 8.4 | 0.076(µg/ml) |  |
 | Vero-adapted Beaudette IBV/ Salvia officinalis, |  |  |  | 36.7 | 0.003(µg/ml) |  |
 |  |  |  |  | 17.1 | 0.017(µg/ml) |  |
 | Vero-adapted Beaudette IBV/Desmodium canadense |  |  |  |  |  |  |
[26] | SARS-COV pseudovirus/ HEK293T-ACE2 | Sanguisorba/ Rosaceae | Virus inhibition, | Â | NR | NR | Â |
[35] | HCo-229E/ Epithelial colorectal adenocarcinoma cells(Caco-2) | Extract/ Pelargonium sidoides/ Geraniaceae | SI, EC50, Virus titer | 72 h |  > 2.3 | NR |  |
[51] | SARS-COV / Vero E6 | Ferruginol | SI, EC50, | 72 h | 58 | 1.39 (µM) |  |
 |  | Dehydroabieta-7-one |  |  | 76.3 | 4 |  |
 |  | Sugiol |  |  | NR | n.t |  |
 |  | Cryptojaponol |  |  |  < 7.9 |  > 10 |  |
 |  | 8â-hydroxyabieta-9(11),13-dien-12-one |  |  |  > 510 | 1.47 |  |
 |  | 7â-hydroxydeoxycryptojaponol |  |  | 111 | 1.15 |  |
 |  | 6,7-dehydroroyleanone |  |  | 16.2 | 5.55 |  |
 |  | 3â,12-diacetoxyabieta-6,8,11,13-tetraene |  |  | 193 | 1.57 |  |
 |  | Pinusolidic acid |  |  | 159 | 4.71 |  |
 |  | Forskolin |  |  | 89.8 | 7.5 |  |
 |  | Cedrane-3â,12-diol |  |  | NR |  > 0 |  |
 |  | α -cadinol |  |  | 17.3 | 4.44 |  |
 |  | Betulinicacid |  |  |  < 15 |  > 10 |  |
 |  | Betulonic acid |  |  | 180 | 0.63 |  |
 |  | Hinokinin |  |  | NR |  > 10 |  |
 |  | Savinin |  |  |  > 667 | 1.13 |  |
 |  | 4,4 ′ -O-benzoylisolaricires-inol |  |  | N.C | n.t |  |
 |  | Honokiol |  |  | 13.7 | 6.50 |  |
 |  | Magnolol |  |  | 18 | 3.80 |  |
 |  | Curcumin |  |  | NR |  > 10 |  |
[52] | SARS-COV / Vero E6 | Supernatant of Cibotium barometz | SI, EC50 | 72 h |  > 59.4 | 8.42 (μg/ml) |  |
 |  | 70% ethanol precipitated fraction of Cibotium barometz |  |  | NR |  > 10(μg/ml) |  |
 |  | Dried rhizome of Gentiana scabra |  |  |  > 57.5 | 8.70(μg/ml) |  |
 |  | The tuber of Dioscorea batatas |  |  |  > 62.0 | 8.06(μg/ml) |  |
 |  | The dried seed of Cassia tora |  |  |  > 59.3 | 8.43(μg/ml) |  |
 |  | The dried stem, with leaf of Taxillus chinensis |  |  |  > 92.8 | 5.39(μg/ml) |  |
[55] | PEDV/ Vero cells | Oleanane triterpenes2 / Theaceae | SI, EC50 | 72 h | 13.39 ± 0.67 | 1.94 ± 0.39 (µM/L) |  |
 |  | Oleanane triterpenes3 / Theaceae |  |  | 5.75 ± 0.75 | 1.09 ± 0.22 (µM/L) |  |
 |  | Oleanane triterpenes6 / Theaceae |  |  | 44.54 ± 8.34 | 0.28 ± 0.09 (µM/L) |  |
 |  | Oleanane triterpenes7 / Theaceae |  |  | 7.99 ± 0.28 | 0.91 ± 0.07 (µM/L) |  |
 |  | Oleanane triterpenes8 / Theaceae |  |  | 12.98 ± 2.34 | 0.06 ± 0.02 (µM/L) |  |
 |  | Oleanane triterpenes9 / Theaceae |  |  | 32.72 ± 6.22 | 0.28 ± 0.11 (µM/L) |  |
 |  | Oleanane triterpenes10 / Theaceae |  |  | 9.4 ± 1.04 | 2.90 ± 0.25 (µM/L) |  |
 |  | Oleanane triterpenes11 / Theaceae |  |  | 14.75 ± 1.62 | 0.93 ± 0.22 (µM/L) |  |
 |  | Oleanane triterpenes13 / Theaceae |  |  | 6.68 ± 0.14 | 0.34 ± 0.01 (µM/L) |  |
 |  | Oleanane triterpenes15 / Theaceae |  |  | 6.42 ± 0.58 | 3.70 ± 0.68 (µM/L) |  |
[56] | Porcine epidemic diarrhea virus (PEDV)/ Vero cells | Coumarins/ Saposhnikovia divaricate1/ Umbelliferae | SI, EC50 | 72 h |  > 6.25 ± 0.85 | 16.25 ± 1.97 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate2/ Umbelliferae |  |  |  > 5.85 ± 0.80 | 17.36 ± 2.12 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate3/ Umbelliferae |  |  |  > 5.11 ± 0.47 | 19.70 ± 1.66 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate4/ Umbelliferae |  |  | 4.07 ± 0.25 | 3.84 ± 0.45 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate5/ Umbelliferae |  |  |  > 23.90 ± 4.11 | 4.28 ± 0.64 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate6/ Umbelliferae |  |  | 7.67 ± 0.04 | 1.09 ± 0.06 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate7/ Umbelliferae |  |  | 8.21 ± 0.40 | 1.22 ± 0.09 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate8/ Umbelliferae |  |  | 7.89 ± 0.97 | 0.60 ± 0.03 (µM/L) |  |
 |  | Coumarins/ Saposhnikovia divaricate9/ Umbelliferae |  |  |  > 5.58 ± 0.41 | 18.00 ± 1.25 (µM/L) |  |
[57] | IBV/ Vero cells | Houttuynia cordata (Saururaceae) | Virus inhibition | 1Â h | NR | NR | Â |
 |  | Glycyrrhizinate diammonium (GD) |  |  |  |  |  |
 | IBV/ chicken embryo kidney (CEK) cells | Houttuynia cordata (Saururaceae) |  |  |  |  |  |
 |  | Glycyrrhizinate diammonium (GD) |  |  |  |  |  |
[8] | (IBV) a chicken coronavirus/ Vero cells | Rhodiola rosea, Nigella sativa, Sambucus nigra | Virus titer | 3d | NR | NR | Â |
[36] | MERS-COV-2 strain EMC/2012/ MRC-5 | Griffithsin (GRFT)/ Wrangeliaceae | Virus titer | 45Â h | NR | NR | Â |
[59] | SARS-COV strain PUMC01 F5 / VeroE6 | Forsythiae Fructus | SI | 72Â h | 1.4 | NR | Â |
 |  | Scutellariae Radix |  |  | 1.0 | NR |  |
 |  | Astragali Radix |  |  | 1.7 | NR |  |
 |  | Bupleuri Radix |  |  |  < 1 | NR |  |
 |  | Glycyrrhizae Radix |  |  |  < 1 | NR |  |
 |  | Cinnamomi Cortex (CCE) |  |  | 6.6 | NR |  |
 |  | Ethanol extract of CC (Fr.1) |  |  | 5.2 | NR |  |
 |  | Butanol fraction of CC (Fr.2) |  |  | 5.5 | NR |  |
 |  | Aqueous fraction of CC (Fr.3) |  |  | 3.9 | NR |  |
 |  | Ethylacetate fraction of CC (Fr.4) |  |  | 3.4 | NR |  |
 |  | Caryophylli Flos (CFE) |  |  | 12.9 | NR |  |
 |  | Ethanol extract of CF (Fr.1) |  |  | 5.4 | NR |  |
 |  | Butanol fraction of CF (Fr.2) |  |  | 20.9 | NR |  |
 |  | Aqueous fraction of CF (Fr.3) |  |  | 23.4 | NR |  |
 |  | Ethylacetate fraction of CF (Fr.4) |  |  | 7.3 | NR |  |
[50] | SARS-COV-2/ Vero E6 | Artemisinin(LG0019527) | Virus inhibition | 1Â h | NR | NR | Â |
[48] | HCoV-NL63/ LCC-MK2 | Trypthantrin | Virus titer | 48Â h | NR | NR | Â |
 |  | Indigodole B |  |  |  |  |  |
[6] | SARS-COV‑2/ Vero E6 cells | Arteether | SI, EC50, | 24 h | 6.42 | 31.86 ± 4.72 µM |  |
 |  | Artemether |  |  |  | 3.13 | 73.8 ± 26.91 |
 |  | Artemisicacid |  |  |  | 3.3 |  > 100 |
 |  | Artemisinin |  |  |  | 3.11 | 64.45 ± 2.58 |
 |  | Artemisone |  |  |  | 4.03 | 49.64 ± 1.85 |
 |  | Dihydroartemisinin |  |  |  | 2.38 | 13.31 ± 1.24 |
 |  | Artesunate |  |  |  | 5.1 | 12.98 ± 5.3 |
 |  | Arteannuin |  |  |  | 7 | 10.28 ± 1.12 |
 |  | lumefantrine |  |  | 4.4 | 23.17 ± 3.22 |  |
[46] | SARS-COV-2/ HepG2 | Andrographolide | Virus inhibition | 48Â h | 2398 | NR | Â |
 | SARS-COV-2/ imHC |  |  |  | 1310 | NR |  |
 | SARS-COV-2/ HK-2 |  |  |  | 1003 | NR |  |
 | SARS-COV-2/ Caco-2 |  |  |  | 1538 | NR |  |
 | SARS-COV-2/ Caco-3 |  |  |  | 1707 | NR |  |
 | SARS-COV-2/ SH-SY5Y |  |  |  | 388 | NR |  |
[40] | SARS-COV‑2/ Vero E6 | Resveratrol | EC50 | 2 h | NR | 66 µM |  |
 |  | Pterostilbene |  |  |  | 19 µM |  |
[10] | SARS-COV-2/ Vero E6 | Homorringtonine | EC50 | 48 h | NR | 2.55 μM |  |
 |  | Emetine |  |  |  | 0.46 μM |  |
[31] | SARS-COV-2/ Vero E6 | Phillyrin (KD-1) | Virus inhibition | 72Â h | 30.66 | NR | Â |
 | HCoV-229E/ Vero E6 |  |  |  | 16.02 |  |  |
[32] | SARS-COV-2/ Vero E6 | Liu Shen capsule | Virus inhibition | 72Â h | 8.18 | NR | Â |
[38] | SARS-COV/ Vero E6 | Griffithsin | SI, EC50 | 3d |  > 164 | 0.61 µg/ml |  |
[24] | SARS-COV-2/ Vero E6 | Corilagin (RAI-S-37) | SI, EC50 | 24 h | NR | 0.13 μmol/L |  |
[45] | SARS-COV-2/ Huh-7 | EGYVIR | Virus inhibition | 3d | NR | NR | Â |
[11] | SARS-COV/ Vero cells | Glycyrrhizin | SI, EC50 | 72 h |  > 67 | 300 µg/ml |  |
[21] | HCoV-C43/ MRC-5 human lung cell | Tetrandrine | SI | 4d | 40.19 | NR | Â |
 |  | Fangchinoline |  |  | 11.46 | NR |  |
 |  | Ceparanthine |  |  | 13.63 | NR |  |
[29] | SARS-COV/ Vero | L. nobilis | SI | 48Â h | 4.2 | NR | Â |
 |  | T. orientalis |  |  | 3.8 | NR |  |
 |  | J. oxycredrus ssp. Oxycedrus |  |  | 3.7 | NR |  |
 |  | Pyramidalis |  |  | 1.5 | NR |  |
 |  | P. palaestina |  |  |  > 1 | NR |  |
 |  | S. officinalis |  |  |  > 1 | NR |  |
 |  | S. thymbra |  |  | NR | NR |  |
 |  | Acyclovir |  |  | NR | NR |  |
 |  | Glycyrrhizin |  |  |  | 1.2 | NR |